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Cryptic Intragenic Deletion of the SHOX Gene in a Family 
with Léri-Weill Dyschondrosteosis Detected by Multiplex 
Ligation-Dependent Probe Amplifi cation (MLPA)
ABSTRACT
LWD is associated to SHOX haploinsuffi ciency, in most cases, due to gene 
deletion. Generally FISH and microsatellite analysis are used to identify 
SHOX deletion. MLPA is a new method of detecting gene copy variation, 
allowing  simultaneous analysis of several regions. Here we describe the 
presence of a SHOX intragenic deletion in a family with LWD, analyzed 
through different methodologies. Genomic DNA of 11 subjects from one 
family were studied by microsatellite analysis, direct sequencing and 
MLPA. FISH was performed in  two affected individuals. Microsatellite anal-
ysis showed that all affected members shared the same haplotype suggest-
ing the involvement of SHOX. MLPA detected an intragenic deletion 
involving exons IV-VIa, which was not detected by FISH and microsatellite 
analysis. In conclusion, the MLPA technique was proved to be the best so-
lution on detecting this small deletion, it has the advantage of being less 
laborious also allowing the analysis of several regions simultaneously. 
(Arq Bras Endocrinol Metab 2008; 52/8:1382-1387)
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RESUMO
Deleção Críptica Intragênica do Gene SHOX em uma Família com 
Discondrosteose de Léri-Weill Detectada por Multiplex Ligation-De-
pendent Probe Amplifi cation (MLPA).
Discondrosteose de Léri-Weill (DLW) está associada à haploinsufi ciência do 
gene SHOX resultante, principalmente, de deleções. Geralmente, o FISH e a 
análise de microssatélites são os métodos utilizados para a identifi cação des-
tas deleções. MLPA é um novo método para detectar variações do número de 
cópias gênicas, permitindo uma análise simultânea de várias regiões. Aqui, 
descrevemos uma pequena deleção intragênica no SHOX em uma família 
com DLW analisada por diferentes metodologias. DNA genômico de 11 mem-
bros de uma família foram estudados por microssatélites, seqüenciamento 
direto e MLPA. FISH foi realizado em dois indivíduos afetados. Os microssa-
télites demonstraram que todos os membros afetados apresentavam o mes-
mo haplotipo, sugerindo o envolvimento do SHOX. MLPA identifi cou uma 
deleção intragênica envolvendo os éxons IV-VIa, que não foi detectada pelo FISH 
e pelos microssatélites. Conclui-se que o MLPA demonstrou melhor reso-
lução para detectar esta pequena deleção, com a vantagem de ser menos 
trabalhoso e permitir a análise de várias regiões simultaneamente. (Arq Bras 
Endocrinol Metab 2008; 52/8:1382-1387)
Descritores: Discondrosteose de Léri-Weill; SHOX; Deleção intragênica; 
MLPA
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INTRODUCTION
In 1997, two independent groups identifi ed a gene related to stature (1,2): short stature homeobox con-
taining gene (SHOX) [MIM 312865], located within 
the pseudoautosomal region 1 (PAR 1) of the short 
arms of sex chromosomes. They found it to be compo-
sed of 7 exons and having about 40 Kb (3).
This gene belongs to a family of genes that encode 
a cell-specifi c homeodomain protein of the paired like 
type involved in cell cycle and growth regulation (4). 
This protein, expressed in high levels in osteogenic 
cells, binds to DNA in a sequence-specifi c manner and 
acts as a transcriptional activator, regulating the expres-
sion of others genes also involved in growth process 
(4). SHOX protein may also function as a repressor of 
chondrocytes differentiation within the growth plate, 
then SHOX haploinsuffi ciency may result in premature 
terminal differentiation of proliferative chondrocytes, 
with progression to the hypertrophic phenotype and 
accelerated growth plate fusion (5). 
SHOX haploinsuffi ciency is associated to Turner-
like phenotype, Léri-Weill dyschondrosteosis (LWD) 
and also idiopathic short stature. LWD [MIM 
127300] is a dominant inherited skeletal dysplasia 
characterized by disproportionate short stature, me-
somelic limb shortening and the Madelung deformi-
ty of the forearm, with bowing of the radius and 
dorsal dislocation of the distal ulna (6). The geno-
type–phenotype correlation is weak and incomplete 
expression in families with LWD has been demons-
trated, with some patients carring SHOX mutations, 
only presenting short stature without the Madelung 
deformity (7). Heterozygous defects in SHOX have 
been identifi ed in 56-100% of LWD cases. Variability 
in the detection rates can often be explained by diffe-
rences in cohort composition, clinical criteria or mu-
tation detecting methods (7).
About two thirds of SHOX gene defects are caused 
by deletions (8). Fluorescence in situ hybridization 
(FISH) technique, microsatellite analysis and Southern 
blotting are the most common techniques used to 
identify these deletions. Recently, a new methodology 
was developed to detect gene copy variation, the Multi-
plex Ligation-Dependent Probe Amplifi cation (MLPA). 
It is based on the simultaneous hybridization of several 
probes followed by a multiplex PCR amplifi cation. In 
one reaction, different regions within and around the 
gene are analyzed (9).
In the present study, we describe the presence of 
SHOX intragenic deletion in a family with LWD, eva-
luated through several distinct molecular strategies in-
cluding MLPA technique.
SUBJECTS AND METHODS
Patients
This study was approved by the Ethics Committee of 
the Hospital das Clinicas of the University of Sao Paulo 
Medical School, University of Sao Paulo. The patients 
or tutors gave their written informed consent.
The index case is an apparently healthy Brazilian 
girl of mixed ethnicity, with short stature noticed by 
her parents at 6 years of age. She was born at term by 
vaginal delivery after an uneventful pregnancy, with 
normal birth weight (3,600 g). She is the fi rst child of 
nonconsanguineous parents. Both parents are short, 
her father’s height is 159 cm (-2.4 SD) and her mother’s 
height is 149 cm (-2.2 SD). The patient was referred to 
our hospital at 11 years of age. At that time, she was 
prepubertal and presented with short stature (height 
standard deviation score [SDS] = -3.4) and normal 
weight (body mass index SDS = 0.6). Physical examina-
tion disclosed a high arched palate, cubitus valgus, dis-
proportional body proportion with short limbs (sitting 
height:height for age SDS = +4.5) and mesomelia 
(upper and lower arm length SDS of -4.7 and -5.5, 
respectively). No Madelung or other skeletal deformity 
was observed in the patient and in her fi rst-degree rela-
tives. Her father was not available for better phenotype 
characterization. However, a careful review of her fami-
ly history identifi ed 1 aunt and 2 second-degree relati-
ves (Figure 1) from paternal side with disproportionate 
short stature and Madelung deformity (Figure 2), fi n-
dings that indicated Léri-Weill dyschondrosteosis.
Results of routine laboratory assessments and hor-
monal measurement were normal. Patient’s bone age 
was of a 11 year-old and no radiology signal of Made-
lung deformity was observed.
Cytogenetic analysis
Chromosome analysis was performed on chromosomal 
spreads obtained from peripheral blood lymphocyte 
cultures of the patients using standard karyotyping te-
chniques with G-banding. FISH methodology was car-
ried out in lymphocyte metaphase spreads, using 
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Figure 1. Family heredogram showing that all affected members shared the same haplotype suggesting the involvement of SHOX.
Figure 2. Madelung deformity in patient II.4.
biotinylated cosmid LLNOYCO3′M′34F5 as a probe, 
which contains exons III to VIb of SHOX (10). The 
analysis was performed using the Karyotyping Software 
Macktype v.5.4.1 and Mackprobe v. 4.0 (Perceptive 
Scientifi c Instruments Inc., UK).
Molecular Analysis 
Genomic DNA was isolated from peripheral blood leu-
kocytes using the salt precipitation method (11). For 
microsatellite analysis, the markers SHOX CA repeat, 
DYS290, DXYS10093, DXYS10096 and DXYS234 
were used. CA repeat is an intragenic marker identifi ed 
in the 5’ untranslated region of exon I. DYS290 and 
DXYS10093 are intragenic markers. DXYS10096 is 3’ 
fl anking the gene, located at an important region appa-
rently implicated in etiopathogenesis of LWD (12). 
DXYS234 is located downstream of SHOX approxima-
tely 2 cM from the Xp telomere (Figure 3). They were 
amplifi ed from the family genomic DNA using fl uores-
cent labeled primers. The PCR products were submit-
ted to electrophoresis in the ABI PRISM 310 automatic 
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sequencer (Applied Biosystems, Foster City, CA, USA) 
and the analysis was made by GeneScan software (Ap-
plied Biosystems, Foster City, CA, USA).
Genomic DNA was amplifi ed by PCR and sequenced 
on an ABI PRISM 3100 (Applied Biosystems, Foster City, 
CA, USA) automatic sequencer using the fl uorescent di-
deoxy-terminator method and specifi c intronic primers, 
previously described for exons II to VI of SHOX (13).
MLPA analysis of SHOX and PAR 1 region was 
carried out using the commercial Kit P018-C1 SHOX 
(MCR Holland, Amsterdam, The Netherlands). This 
kit contains 8 probes for SHOX exons, 13 for SHOX 
surround area and 13 for the other X regions. Six indi-
viduals with normal height and body proportions were 
used as control for PAR1 deletion. As deletion control, 
four individuals with SHOX deletion detected by FISH 
were used. The manufacturer instructions were follo-
wed and data was analyzed using Coffalyser software 
(MCR Holland, Amsterdam, The Netherlands).
RESULTS
The index case (III.2) and one second-degree relative 
(II.4) presented normal karyotype with presence of 
SHOX in FISH analysis (Figure 4). 
Microsatellite analysis did not display any deletion. 
This analysis showed that all affected members (I.2, 
II.1, II.2, II.4, III.2 and III.3) shared the same haplo-
type (Figure 1). In the individuals I.2, I.3, III.2, III.4 
the direct sequencing did not identify mutations in the 
encoding region and splicing sites. 
An intragenic deletion of exons IV to VIa in hete-
rozygous form was detected in 5 affected members 
(I.2, II.2, II.4, III.2 and III.3) by MLPA (Figure 5). It 
was not possible to perform MPLA analysis in the affec-
ted member II.1 due to insuffi cient genomic DNA and 
the impossibility to obtain new sample.
DISCUSSION
Several methodologies have been used in SHOX muta-
tion screening, but the molecular defect remains uni-
dentifi ed in a signifi cant proportion of LWD cases. 
Several factors can be involved in the failure to detect 
mutations in SHOX gene. First of all an alternative cli-
nical diagnosis should be excluded. Secondly, the mo-
lecular defect may be present in unscreened areas of the 
SHOX gene (14). 
SHOX gene deletion is the most common cause of 
LWD and it is usually detected by FISH or microsa-
tellite analysis. However, in this family both techniques 
failed to detect the intragenic deletion which was de-
tected by MLPA. FISH is a laborious and expensive 
technique that uses biotinylated specifi c probes and 
permits their visualization in a fl uorescent microscope. 
In normal individuals with two copies of SHOX, two 
fl uorescent signals are visible in each metaphase. In de-
Figure 3. Schematic representation of microsatellite markers position on PAR 1 [Adapted from Benito-Sanz and cols. (12)].
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Figure 4. Fluorescence in situ hybridization of cosmid 
LLNOYCO3′M′34F5 to metaphase chromosome in the index 
case. Note the presence of two signals on Xp.
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Figure 5. Electropherograms of MLPA runs. Each peak corresponds to amplifi cation of one probe. A - Normal control. B - Index 
case: Comparisons of relative peak areas indicate heterozygous deletion involving exons IV, V and VIa. 
letions of one copy, only one signal is visible. This me-
thodology does not allow the detection of small 
deletions. In this family the clone LLNOYCO3”M”34F5 
of 42 Kb hybridized to the SHOX gene, despite the 
presence of the small deletion. 
Microsatellite analysis uses fl uorescent primers and 
an automatic sequencer. This technique is able to de-
tect small deletions but in case of big genes as SHOX, 
it is important to analyze several markers to cover the 
entire gene. Besides that, parents’ DNA analysis is ne-
cessary to characterize the presence of small deletions. 
This analysis showed that all affected members shared 
the same haplotype indicating the involvement of 
SHOX region. However, since the markers were not 
located at the deleted region, it was not detected by 
microsatellite analysis. No mutation was detected in 
SHOX exons and splicing regions by direct sequencing. 
This family presented an apparently normal SHOX 
gene, despite the typical phenotype.
MLPA is a relatively simple technique that is com-
mercially available for SHOX analysis. In this family the 
MLPA detected a deletion involving exons IV to VIa in 
all affected members analyzed. Analyzing the probes 
and DYS290 marker positions, it was possible to esti-
mate that deletion could be 4 to 14 kb in length.
It is noteworthy that microdeletions involving 
SHOX are much more prevalent than intragenic SHOX 
mutations (15). MLPA has been an important tool for 
the diagnosis of patients with SHOX microdeletions. 
Recently, Fukami and cols. reported three patients with 
LWD with apparently normal SHOX according to con-
ventional screening techniques. MLPA also detected an 
heterozygous deletion involving exons IV and V in one 
case, exons IV–VIa in the second case and exons IV–
VIb in the third case (8).
In conclusion, MLPA technique for SHOX analysis 
has the best resolution to detect small deletions and has 
the advantage to be less laborious and should be used 
to identify cryptic SHOX intragenic deletions.
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